ALEXANDRIA, Va., Dec. 9 -- United States Patent no. 12,492,260, issued on Dec. 9, was assigned to IGI THERAPEUTICS SA (La Chaux-de-Fonds, Switzerland).
"Antibodies that bind to IL1RAP and uses thereof" was invented by Julie Macoin (La Chaux-de-Fonds, Switzerland), Amelie Croset (La Chaux-de-Fonds, Switzerland), Jeremy Loyau (La Chaux-de-Fonds, Switzerland), Thierry Monney (La Chaux-de-Fonds, Switzerland), Lamine Mbow (La Chaux-de-Fonds, Switzerland), Marie-Agnes Doucey (La Chaux-de-Fonds, Switzerland) and Valentina Labanca (La Chaux-de-Fonds, Switzerland).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to antibodies which specifically bind to human IL1RAP and my also bind to cynom...